Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860727 · ClinicalTrials.gov registry record
Comparison of Ophthalmoscopy Findings Using PanOptic vs PanOptic + iExaminer
A clinical trial, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 40
- Enrollment target
NCT03860727: Completed study, sponsored by State University of New York at Buffalo.
NCT03860727 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860727 has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
To examine how helpful the iExaminer will be as a training aid for medical students. The investigators will look into whether 1) it helps the medical students find pertinent eye findings for certain diagnoses and 2) it improves the medical students comfort level compared to using the PanOptic alone.
Primary Outcome
Students will be provided with survey questions to assess their confidence level in accurately diagnosing fundus findings using iExaminer combined with Panoptic vs Panoptic alone
Interventions
- DIAGNOSTIC_TEST Welch Allyn IExaminer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2019-05-07 |
What the finished NCT03860727 record still lists
NCT03860727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Welch Allyn IExaminer is the first listed.
NCT03860727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03860727 about?
NCT03860727 is a clinical study titled "Comparison of Ophthalmoscopy Findings Using PanOptic vs PanOptic + iExaminer". To examine how helpful the iExaminer will be as a training aid for medical students. The investigators will look into whether 1) it helps the medical students find pertinent eye findings for certain diagnoses and 2) it improves the medical students comfort level compared to using the PanOptic alone.
What is the current status of trial NCT03860727?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-08-28. Estimated completion is 2019-05-07.
What interventions are being tested in trial NCT03860727?
The interventions under investigation include: Welch Allyn IExaminer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03860727?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI